MSc Precision Medicine

University of Liverpool

The programme’s mission is centred around improving patient treatment through the optimisation, of current treatments, understanding variability in patient responses from both an efficacy and safety perspective, and formulation of advanced personalised therapeutics, such as gene and cellular therapies. The programme is led by internationally recognised clinical and non-clinical experts in the field of pharmacology, toxicology, and precision medicine based in the world-renowned Wolfson centre for Personalised Medicine at the University of Liverpool. In addition, teaching will be delivered by experts in the field from the biotechnology and pharma industry. At the heart of the programme are modules centred around key topics in the field of pharmacology and personalised medicine. Advances in Personalised Healthcare will provide students with learning opportunities in understanding the principle of pharmacogenomics as well as other examples of personalised or stratified healthcare in both clinical and drug development settings. Linked to this is the Experimental Medicine and Clinical Pharmacology module, where students will learn how clinical trials are conducted, and how risk assessment needs to be managed in early phase trials, particularly for these new therapeutic modalities.